Brought to you by 
Neurostim company SetPoint sells $4mm in Series B financing; adds $5mm
08 Aug 2013
Executive Summary
SetPoint Medical (formerly Innovative Metabolics; developing a neurostimulation implant that stops inflammation caused by autoimmune and other diseases) raised $4mm in its Series B financing from two unnamed investors.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neurostim company SetPoint sells $4mm in Series B financing; adds $5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice